课题基金 / 基金详情

REGULATION OF CELL PROLIFERATION

REGULATION OF CELL PROLIFERATION
细胞增殖的调节
批准号:
2750472
负责人:
MICHAEL J. GETZ
金额:
$24.81万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1995
资助国家:
美国
项目状态:
已结题
起止时间:
1995-08-01 至 1999-07-31

项目摘要

项目成果

MICHAEL J. GETZ的其他基金

相似基金

相关文献

中文摘要
翻译
描述(改编自申请人的摘要):细胞骨架 β-和γ-肌动蛋白基因编码主要的结构蛋白 细胞微丝,是各种生长类别的成员 被称为细胞“即刻早期”(IE)基因的因子调节基因。 虽然这些基因的显著特征是它们的快速转录 对增殖刺激、肌肉特异性肌动蛋白的激活 基因通常只在末端分化过程中表达。 肌源性细胞系。但是,此规则的一个例外是 血管平滑肌(VSM)α-肌动蛋白基因 在平滑肌细胞分化过程中的激活,也表达了 间质中的“肌成纤维细胞”--一种与 对生长因子、细胞因子和炎症的增殖反应 刺激物。与在细胞增殖中的作用一致,申请者具有 最近发现,VSM-肌动蛋白启动子有可能被 细胞IE基因在血清刺激的成纤维细胞中的表达 文化。申请人现在提议检验细胞-- 特定类型的转录抑制机制起作用,在 部分,用于VSMα-肌动蛋白在 肌源性细胞和成纤维细胞。具体来说,申请人 假设成纤维细胞中的沉默是由于干扰 转录增强因子1(TEF-1)或密切相关的 相关蛋白协同激活VSMα-肌动蛋白 抄写。此外,申请者还提出了一种调解机制 通过最近发现的单链DNA(SsDNA)结合蛋白。 然而,在未分化的成肌细胞中,定点突变 研究清楚地表明,抑制VSMα-的机制- 肌动蛋白转录不同。
英文摘要
DESCRIPTION (adapted from the applicant's abstract): The cytoskeletal beta- and gamma-actin genes encode the principal structural proteins of cellular microfilaments and are members of a diverse class of growth factor-regulated genes termed cellular "immediate early" (IE) genes. While the salient feature of these genes is their rapid transcriptional activation in response to proliferation stimuli, muscle-specific actin genes are generally expressed only during terminal differentiation of cells of myogenic lineage. An exception to this rule, however, is the vascular smooth muscle (VSM) alpha-actin gene which, in addition to activation during smooth muscle cell differentiation, is also expressed in stromal "myofibroblasts"-specialized cell types associated with proliferative responses to growth factors, cytokines, and inflammatory stimuli. Consistent with a role in cell proliferation, the applicant has recently shown that the VSM-actin promoter has the potential to be expressed as a cellular IE gene in serum-stimulated fibroblasts in culture. The applicant now proposes to test the hypothesis that cell- type-specific transcriptional repression mechanisms are responsible, in part, for the differential patterns of VSM alpha-actin expression in myogenic cells and in fibroblasts. Specifically, the applicant postulates that silencing in fibroblasts results from interference with the ability of transcriptional enhancer factor 1 (TEF-1), or a closely related protein, to synergistically activate VSM alpha-actin transcription. Moreover, the applicant proposes a mechanism mediated by recently identified single-stranded DNA (ssDNA) binding proteins. In undifferentiated myoblasts, however, site- directed mutagenesis studies clearly indicate that the mechanisms which repress VSM alpha- actin transcription differ.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CAF, A COACTIVATOR OF FOS, AND BREAST CANCER
  • 批准号:
    2447341
  • 项目类别:
  • 资助金额:
    $19.27万
  • 财政年份:
    1997
  • 负责人:
    MICHAEL J. GETZ
  • 依托单位:
CAF, A COACTIVATOR OF FOS, AND BREAST CANCER
  • 批准号:
    2837758
  • 项目类别:
  • 资助金额:
    $19.85万
  • 财政年份:
    1997
  • 负责人:
    MICHAEL J. GETZ
  • 依托单位:
REGULATION OF CELL PROLIFERATION
  • 批准号:
    2460124
  • 项目类别:
  • 资助金额:
    $23.89万
  • 财政年份:
    1995
  • 负责人:
    MICHAEL J. GETZ
  • 依托单位:
REGULATION OF CELL PROLIFERATION
  • 批准号:
    2232604
  • 项目类别:
  • 资助金额:
    $24.47万
  • 财政年份:
    1995
  • 负责人:
    MICHAEL J. GETZ
  • 依托单位:
海外基金